Literature DB >> 24493311

Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.

Neil Mehta1, Jennifer L Dodge, John Paul Roberts, Ryutaro Hirose, Francis Y Yao.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24493311      PMCID： PMC4395854          DOI： 10.1002/lt.23847

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  Selecting patients with hepatocellular carcinoma for liver transplantation: who should receive priority?

Authors:  Fateh Bazerbachi; Elizabeth Aby; John R Lake
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

2.  Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?

Authors:  A Cucchetti; M Cescon; V Bertuzzo; E Bigonzi; G Ercolani; M C Morelli; M Ravaioli; A D Pinna
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

3.  Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.

Authors:  Neil Mehta; Jennifer L Dodge; Aparna Goel; John Paul Roberts; Ryutaro Hirose; Francis Y Yao
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

4.  Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma.

Authors:  Kristin Berry; George N Ioannou
Journal:  Liver Transpl       Date:  2013-06       Impact factor: 5.799
  4 in total
  2 in total

Review 1.  The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Alessandra Mangia; Salvatore Gruttadauria; Adriana Toro; Isidoro Di Carlo; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Michele Malaguarnera
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

Review 2.  Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Salvatore Gruttadauria; Adriana Toro; Giulia Malaguarnera; Nicoletta Bertino; Michele Malaguarnera; Mariano Malaguarnera; Isidoro Di Carlo
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.